reports
- Hybridan Team
- Colin Smith
Polarean Imaging | Ascend representative agreement
Polarean has signed a Representative Agreement with Ascend Imaging LLC (Ascend) covering four specific US states. Under the agreement Ascend will act as a non-exclusive, independent manufacturer's representative supporting the promotion and sale of Polarean's Xenon MRI lung-imaging platform. Polarean has potential upside many times its current market capitalisation, we calculate, based on observable deal metrics and our NPV analysis, while the valuation is so low, it could attract take-over inte...
FDA expands XENOVIEW® indication to include children from six years of...
FDA expands XENOVIEW® indication to include children from six years of age Increases number of eligible patients by approximately one million DURHAM, NC and LONDON, June 02, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging ("MRI") of the lungs, announces that the US Food and Drug Administration (“FDA”) has approved the Company’s Supplemental New Drug Application (“NDA”) to expand the indication of XENOVIEW®. This approval immediately lowers the minimum pa...
- Colin Smith
Polarean Imaging | FDA extends use of XENOVIEW® to 6-year-olds
The US Food and Drug Administration (FDA) has approved Polarean's proven Xenon MRI platform for use in paediatric patients as young as six years old from the previous limit of 12. This approval increases the number of eligible patients by c1 million, confirming a total addressable market (TAM) in the US of cUS$2bn for use of the technology in evaluating ventilation. The FDA decision has come a little ahead of previous guidance. Approval for use in gas exchange, which remains subject to a clinica...
- Hybridan Team
Hybridan Small Cap Feast: 28/05/2025
28th May 2025 @HybridanLLP Status of this Note and Disclaimer This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract rel...
- Hybridan Team
Hybridan Small Cap Feast: 22/05/2025
Our daily digest of news from UK Small Caps 22nd May 2025 @HybridanLLP * A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) or similar announcement has been made ***Arranged by type of listing and date of announcement ****Alphabetically arranged Dish of the day Admissions: None Delistings: None What’s baking in the oven? Potential** Initial Public Offerings: 12th May: Cobalt Holdings, a Company create...
- Hybridan Team
Hybridan Small Cap Feast: 19/05/2025
Our daily digest of news from UK Small Caps 19th May 2025 @HybridanLLP * A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) or similar announcement has been made ***Arranged by type of listing and date of announcement ****Alphabetically arranged Dish of the day Admissions: None Delistings: On Friday 16th, Bushveld Minerals left AIM. What’s baking in the oven? Potential** Initial Public Offerings: 1...
Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spect...
Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum 30+ studies across diverse conditions illuminate the unique value of functional lung imaging with Xenon MRI DURHAM, NC and LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging ("MRI") of the lungs, will be featured at the American Thoracic Society’s (ATS) 2025 Respiratory Innovation Summit (RIS), taking place May 16–17 at the Marriott Marquis in San Francisco, Californi...
- Hybridan Team
Hybridan Small Cap Feast: 08/05/2025
Claire Louise Noyce Managing Partner, Chief Executive Birchin Court, 20 Birchin Lane, London EC3V 9DU Tel direct: +44 (0)203 764 2341 Mobile: +44 (0)7894 267 530 Call me on teams E-mail: Whilst it suits me to email now, I do not expect any response outside your own work times. Linkedin: /in/claire-louise-noyce-25b4588a Website: Follow us on X @hybridanllp Follow us on Linkedin Hybridan LLP would love your feedback. Post ...
- Colin Smith
Polarean Imaging | FY24 results – sales growth guidance reiterated
Polarean has more than tripled revenue YoY to US$3.1m for the year to December 2024 and raised the gross margin by 841 basis points, confirming that it is on a path to hyperbolic growth. Almost more importantly, the cost of a Phase III trial for the use of its XENOVIEW® technology in gas exchange has been halved to US$4.0m-US$4.5m. The cash runway has been extended to 2Q26 and the company reiterated revenue guidance for 2025 of US$5.0m-US$6.0m. Polarean has potential upside many times its curren...
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
AYI ACUITY BRANDS INC.
WMS ADVANCED DRAINAGE SYSTEMS INC.
VC VISTEON CORPORATION
TRN TRINITY INDUSTRIES INC.
TMO THERMO FISHER SCIENTIFIC INC.
POWI POWER INTEGRATIONS INC.
NEOG NEOGEN CORPORATION
NDSN NORDSON CORPORATION
MKSI MKS INSTRUMENTS INC.
MCHP MICROCHIP TECHNOLOGY INCORPORATED
LEA LEAR CORPORATION
ICLR ICON PLC
FSS FEDERAL SIGNAL CORPORATION
FORM FORMFACTOR INC.
BRKR BRUKER CORPORATION
BMI BADGER METER INC.
AMAT APPLIED MATERIALS INC.
HPQ HP INC.
ACLS AXCELIS TECHNOLOGIES INC.
AMWD AMERICAN WOODMARK CORPORATION
ENTG ENTEGRIS INC.
FBHS FORTUNE BRANDS HOME & SECURITY INC.
KALU KAISER ALUMINUM CORPORATION
TTC TORO COMPANY
VMI VALMONT INDUSTRIES INC.
ITT ITT INC.
AA ALCOA CORPORATION
NOVT NOVANTA INC
IOVA IOVANCE BIOTHERAPEUTICS INC
ADNT ADIENT PLC
ASTL LEGATO MERGER CORP
CR CRANE HOLDINGS CO
ARM ARM HOLDINGS PLC
PRIM PRIME ENERGY P.E. LTD
ANET ARISTA NETWORKS INC
MTAL MAC COPPER LIMITED
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Major Low Likely in Place on S&P 500 In our 2/25/25 Compass, we discussed our expectation for near-term downside as the S&P 500 and Nasdaq 100 (QQQ) displayed several bearish short-term developments. We also said it likely means at least another 2-4 weeks of consolidation, that one or two 8-10% pullbacks in a given year on the SPX is common (even during bull markets), and to not be surprised if there is a test of the bottom of the range at either 5770-5850 or 5600-5670, where we would be buyers...
WRN WESTERN COPPER AND GOLD
TSLA TESLA INC
TMO THERMO FISHER SCIENTIFIC INC.
SCCO SOUTHERN COPPER CORPORATION
ORI OLD REPUBLIC INTERNATIONAL CORPORATION
MSTR MICROSTRATEGY INCORPORATED CLASS A
KMPR KEMPER CORPORATION
HMN HORACE MANN EDUCATORS CORPORATION
FCX FREEPORT-MCMORAN INC.
FAF FIRST AMERICAN FINANCIAL CORPORATION
AXS AXIS CAPITAL HOLDINGS LIMITED
TKO. TASEKO MINES LIMITED
AIG AMERICAN INTERNATIONAL GROUP INC.
K. KINROSS GOLD CORPORATION
AIZ ASSURANT INC.
19KQ BALWIN PROPERTIES PTY LTD
THG HANOVER INSURANCE GROUP INC.
WRB W. R. BERKLEY CORPORATION
PLTR PALANTIR TECHNOLOGIES
- Hybridan Team
- Jon Levinson
Hybridan Small Cap Feast: 20/03/2025
Our daily digest of news from UK Small Caps @HybridanLLP 20th March 2025 * A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Dish of the day Admissions: One Health Group (AQSE: OHGR), a provider o...
- Colin Smith
Polarean Imaging | Investor update presentation confirms thesis
Polarean held a presentation for investors to recap the investment thesis for its unique technology for visualising lung function and provide real life examples of its Xenon MRI imaging in both research and clinical use. Dr Alan Huang, recently appointed VP Global Sales, provided a positive update on the sales pipeline and process. Polarean reaffirmed existing guidance. However, while there was no new news, the presentation certainly helped demonstrate the enthusiasm with which Polarean's techno...
Thermo Fisher Scientific Inc: 1 director
A director at Thermo Fisher Scientific Inc sold/sold after exercising options 3,775 shares at 532.525USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company'...
- Hybridan Team
- Jon Levinson
Hybridan Small Cap Feast: 10/03/2025
Our daily digest of news from UK Small Caps @HybridanLLP 10th March 2025 * A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Dish of the day Admissions: None Delistings: None W...
- Colin Smith
Polarean Imaging | Xenon MRI pharma research collaboration
Polarean has announced that its Xenon MRI lung imaging has been selected by a leading global pharma company to be included in a clinical trial due to start in 4Q25. This collaboration opens up a new vertical for Polarean but more importantly provides third party validation of the unmatched lung imaging that Polarean's Xenon MRI system provides. Polarean recently announced a better than expected update for FY24 which, in our view, confirms that the company is on the cusp of hyperbolic growth with...
- Hybridan Team
- Jon Levinson
Hybridan Small Cap Feast: 27/02/2025
Our daily digest of news from UK Small Caps @HybridanLLP 27th February 2025 * A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Dish of the day Admissions: Delistings: What’s bak...
- Colin Smith
Polarean Imaging | FY24 update - Even better than expected
Polarean has published a trading update for the year to December which is even better than expected. Revenue for FY24 is anticipated to be US$3.0m-US$3.1m, above guidance of US$2.5m-US$3.0m, and more than treble revenue for FY23; our forecast was US$2.8m. Moreover, net cash at YEFY24 of US$12.1m was well above our forecast of US$10.8m and the company reiterated that it has a cash runway through 1Q26. A YoY jump in sales of over 50% in consumables demonstrates an increase in the number of Xenon M...
Moody's Ratings assigns A3 rating to Thermo Fisher's CHF notes; outloo...
Moody's Ratings (Moody's) assigned an A3 rating to the new senior unsecured CHF-denominated notes offering by Thermo Fisher Scientific Inc. (Thermo Fisher). There are no changes to Thermo Fisher's existing ratings including the A3 senior unsecured long-term ratings and the senior unsecured commercia...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.